Sunitinib 50mg Capsule

Sunitinib 50mg Capsule may cause some adverse impact on the body during the treatment, and most of them resolve on their own. Some common side effects include: Blurred vision
Cough
Nausea
Weakness
Rash
Fever
Abdominal pain
High blood pressure
Stomatitis
Back pain
Taste change
Weight loss
Indigestion
Bleeding gums
Thyroid imbalances
Loss of appetite
Constipation Contact a doctor immediately if you experience any serious or persistent side effects.

Take this medicine as prescribed by your doctor. Sunitinib 50 mg Capsule may be taken with or without food, but it is better to take it at a fixed time every day to get effective results. Swallow the capsule as a whole with a glass of water and don't open, crush, or dissolve it.

It is advisable not to miss a dose. If you miss a scheduled dose of Sunitinib 50mg Capsule, contact your doctor immediately. 

1. Chouhan, J. D., Zamarripa, D. E., Lai, P. H., Oramasionwu, C. U., & Grabinski, J. L. (2007). Sunitinib (Sutent®): A novel agent for the treatment of metastatic renal cell carcinoma. Journal of Oncology Pharmacy Practice, 13(1), 5-15.

2. Navid, F., Christensen, R., Minkin, P., Stewart, C. F., Furman, W. L., & Baker, S. (2008). Stability of sunitinib in oral suspension. Annals of Pharmacotherapy, 42(7-8), 962-966.

3. Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., ... & Casali, P. G. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. The Lancet, 368(9544), 1329-1338.

4.https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021938s13s17s18lbl.pdf

5. Blumenthal, G. M., Cortazar, P., Zhang, J. J., Tang, S., Sridhara, R., Murgo, A., ... & Pazdur, R. (2012). FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors. The oncologist, 17(8), 1108-1113.